BGC101 (EnEPC) Autologous Cell Therapy From Patient's Own Blood for Treatment of Critical Limb Ischemia (CLI)

Clinical trial NCT02805023 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT02805023
Sponsor: BioGenCell Ltd.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Chronic Limb-Threatening Ischemia Peripheral Arterial Disease Peripheral Vascular Disease

Start date: 2016-06-01
Primary completion: 2017-07-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.